Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.
NCT01256125 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2010-12-08
Summary
Allogene MSCs transplantation will be performed in patients with chronic liver diseases through peripheral vein and therapeutic effects including short-term effects and long-term follow-up will be compared and investigated.
Conditions
- Allogene MSCs Transplantation
- Chronic Liver Diseases Patients
- Peripheral Vein
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Eligibility
- Min Age
- 15 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
Countries
- China
Study Locations
More Related Trials
-
Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma
NCT02586285 ·Status: UNKNOWN ·Phase: PHASE1
-
Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma
NCT05701553 ·Status: RECRUITING
-
Liver Cancer Prognosis Investigation Study
NCT06623734 ·Status: NOT_YET_RECRUITING
-
The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene
NCT01786980 ·Status: COMPLETED
-
Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma
NCT02509169 ·Status: UNKNOWN ·Phase: PHASE2
-
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NCT05444478 ·Status: RECRUITING ·Phase: NA
-
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
NCT06644430 ·Status: RECRUITING
-
Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)
NCT05750329 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma
NCT05609695 ·Status: UNKNOWN
-
Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma
NCT00493402 ·Status: COMPLETED ·Phase: PHASE3
-
Advanced Therapies for Liver Metastases
NCT04622423 ·Status: RECRUITING
-
Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC
NCT05484908 ·Status: RECRUITING ·Phase: NA
-
Primary Liver Cancer Cohort of South China
NCT03297255 ·Status: RECRUITING
-
TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma
NCT05555316 ·Status: UNKNOWN ·Phase: PHASE2
-
Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion
NCT00501813 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
NCT05352204 ·Status: COMPLETED
-
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)
NCT04053985 ·Status: UNKNOWN ·Phase: PHASE3
-
Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)
NCT06643533 ·Status: NOT_YET_RECRUITING
-
Proton Beam Therapy for Unresectable Liver Metastasis
NCT04456621 ·Status: COMPLETED ·Phase: NA
-
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma
NCT02851784 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mts105 for Advanced Hepatocellular Carcinoma
NCT06689540 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world Study
NCT05638438 ·Status: UNKNOWN
-
Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC
NCT05002452 ·Status: RECRUITING
-
Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
NCT04319484 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)
NCT01170104 ·Status: UNKNOWN ·Phase: PHASE2